Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.
复制标题

DOI:
10.1016/j.taap.2011.06.006
复制
发表时间:
2011-11-01
影响因子:
3.8
通讯作者:
Richmond, Ann
Richmond, Ann
中科院分区:
医学3区
文献类型:
--
作者:
Raman, Dayanidhi;Milatovic, Snjezana-Zaja;Milatovic, Dejan;Splittgerber, Ryan;Fan, Guo-Huang;Richmond, Ann

文献摘要

参考文献

相似文献

Alzheimer’s disease (AD) is characterized by a progressive cognitive decline and accumulation of neurotoxic oligomeric peptides amyloid-β (Aβ). Although the molecular events are not entirely known, it has become evident that inflammation, environmental and other risk factors may play a causal, disruptive and/or protective role in the development of AD. The present study investigated the ability of the chemokines, macrophage inflammatory protein-2 (MIP-2) and stromal cell-derived factor-1α (SDF-1α), the respective ligands for chemokine receptors CXCR2 and CXCR4, to suppress Aβ-induced neurotoxicity in vitro and in vivo. Pretreatment with MIP-2 or SDF-1α significantly protected neurons from Aβ-induced dendritic regression and apoptosis in vitro through activation of Akt, ERK1/2 and maintenance of metalloproteinase ADAM17 especially with SDF-1α. Intra-cerebroventricular (ICV) injection of Aβ led to reduction in dendritic length and spine density of pyramidal neurons in the CA1 area of the hippocampus and increased oxidative damage 24 h following the exposure. The Aβ-induced morphometric changes of neurons and increase in biomarkers of oxidative damage, F2-isoprostanes, was significantly inhibited by pretreatment with the chemokines MIP-2 or SDF-1α. Additionally, MIP-2 or SDF-1α was able to suppress the aberrant mislocalization of p21-activated kinase (PAK), one of the proteins involved in the maintenance of dendritic spines. Furthermore, MIP-2 also protected neurons against Aβ neurotoxicity in CXCR2−/− mice, potentially through observed up regulation of CXCR1 mRNA. Understanding the neuroprotective potential of chemokines is crucial in defining the role for their employment during the early stages of neurodegeneration.
DOI: 10.1016/j.neures.2006.07.009
发表时间: 2006-11-01
影响因子: 2.9
作者:
Ito, Sachiko;Sawada, Makoto;Isobe, Ken-ichi
通讯作者: Isobe, Ken-ichi
DOI: 10.1074/jbc.m607483200
发表时间: 2007-04-13
影响因子: 4.8
作者:
De Felice, Fernanda G.;Velasco, Pauline T.;Klein, William L.
通讯作者: Klein, William L.
DOI: 10.1038/cdd.2008.95
发表时间: 2008-10-01
影响因子: 12.4
作者:
Khan, M. Z.;Brandimarti, R.;Meucci, O.
通讯作者: Meucci, O.
DOI: 10.1371/journal.pone.0010733
发表时间: 2010-05-20
期刊: PloS one
影响因子: 3.7
作者:
Laurén HB;Lopez-Picon FR;Brandt AM;Rios-Rojas CJ;Holopainen IE
通讯作者: Holopainen IE
DOI: 10.1016/j.neuropharm.2008.06.055
发表时间: 2009-01-01
期刊: NEUROPHARMACOLOGY
影响因子: 4.7
作者:
Asrar, Suhail;Meng, Yanghong;Jia, Zhengping
通讯作者: Jia, Zhengping